Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GE Healthcare to acquire Vital Signs
Under the terms of the agreement, shareholders of Vital Signs will receive $74.50 per share in cash for each Vital Signs share they own. Vital Signs will become
Under the terms of the agreement, shareholders of Vital Signs will receive $74.50 per share in cash for each Vital Signs share they own. Vital Signs will become
Mr Hartnett joins Tepha following an 18 year career with Boston Scientific during which he progressed from field sales, to marketing management, and, most recently, to strategic planning
This newly identified lead is said to be the first from a program being evaluated as a potential treatment for pain and the fifth lead identified since the
Michael Crowley, vice president of business development at PharmaForm, said: “We are very pleased to have been awarded this important contract and with our long relationship with Repros.
The data showed a decrease of 0.02ml in end systolic volume (0.13ml to 0.11ml) and a 38% increase in stroke volume (0.31 ml to 0.43 ml) from three
The co-exclusive agreement continues to cover all of the cardiology and drugs of abuse rapid test products manufactured by the Biosite subsidiary of Inverness and sold under the
Moffitt is the seventh center in this multi-center trial using the Delcath System. Delcath and Moffitt have entered into a clinical research agreement to conduct the Phase III
Following the special clinical protocol assessment process with the FDA and a formal scientific advice meeting with the Committee for Human Medicinal Products of the European Medicines Agency
The Phase IIa study is designed to assess the safety and efficacy of 1% Xoma 629 topical gel compared to a control cream indicated for impetigo. The clinical
The financing was led by X Gen, a family venture fund based in Cleveland, Ohio. It also includes a grant from the Cleveland Clinic Global Cardiovascular Innovation Center